SenoRx (SENO) Inactive

We develop, manufacture and sell minimally-invasive medical devices that are used in the diagnosis and treatment of breast cancer. Our initial product focus has been biopsy systems and breast tissue markers and in January 2008 we launched a radiation balloon catheter for localized partial breast irradiation therapy. With the emergence of clinicians coordinating multi-disciplinary patient care through integrated breast centers, we believe that our ability to provide a broad array of products will enhance our competitive positioning. Since we launched our first breast tissue marker products in 2002, we have established over 1,000 customer accounts. In 2009, we generated net revenues of $55.6 million. The sale of disposable products including our breast biopsy probes, radiation therapy products and tissue markers, accounted for 90.0% of our revenues in 2009.